Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) shares were up 0.4% on Wednesday . The stock traded as high as €19.99 ($20.61) and last traded at €19.79 ($20.40). Approximately 3,072,022 shares changed hands during mid-day trading, The stock had previously closed at €19.72 ($20.33).
Bayer Aktiengesellschaft Stock Down 0.6 %
The firm has a 50-day simple moving average of €20.46 and a two-hundred day simple moving average of €24.88. The stock has a market cap of $19.32 billion, a P/E ratio of -15.25, a PEG ratio of 36.39 and a beta of 0.97. The company has a current ratio of 1.27, a quick ratio of 0.72 and a debt-to-equity ratio of 129.94.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
See Also
- Five stocks we like better than Bayer Aktiengesellschaft
- Short Selling – The Pros and Cons
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Business Services Stocks Investing
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Golden Cross Stocks: Pattern, Examples and Charts
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.